爱尔兰Shire
爱尔兰沙尔(Shire)制药公司.Shire 的战略目标是成为专注于满足专科医生需要的领先专业生物制药公司。其业务主要集中于注意缺陷多动障碍、人类基因疗法以及肠胃与肾脏疾病等领域。这种业务结构的灵活性足以让 Shire 通过收购锁定新的治疗领域，抓住更多的机遇。该公司的引入式授权 (in-licensing) 和并购活动集中在那些具备高度知识产权保护和全球权利的专业市场的产品上。Shire 相信，经过认真挑选的稳定的产品组合以及符合公司战略的规模相对较小的销售队伍将会取得出色的业绩。

As one of the world’s leading specialty biopharmaceutical companies, Shire has emerged as a company fully focused on a single purpose: to enable people with life-altering conditions to lead better lives.

Shire is a global company with offices in the major pharmaceutical markets. Its UK offices are in Basingstoke and its US offices are in Wayne, Pennsylvania.